Skip to main content
Equibles

CSS LLC/IL

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 1103646 CHICAGO, IL
Back to TEVA Full portfolio

Position in TEVA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$917,131
+$101,783 QoQ
Shares Held
27,070
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#347
of 675 holders
Holding Since
Mar 2025
5 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TEVA Over Time

Shares Held

Position Value (USD)

Derivatives in TEVA

reported options exposure · as of Mar 31, 2025
CallValue
$307,400
CallShares
20,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

CSS LLC/IL holds $5,738,432 across 10 Drug Manufacturers - Specialty & Generic names. TEVA ranks #5 (16.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 HIMS
Hims & Hers Health, Inc.
 31,338 $1,086,488
2 NBIX
Neurocrine Biosciences Inc
 6,350 $1,070,229
3 ZTS
Zoetis Inc.
 14,510 $1,042,688
4 UTHR
UNITED THERAPEUTICS Corp
 1,892 $1,025,142
5 TEVA
Teva Pharmaceutical Industries Ltd
This page 		27,070 $917,131
6 TRLV
Trulieve Cannabis Corp.
 29,875 $293,671
7 VTRS
Viatris Inc
 11,120 $176,585
8 YCBD
cbdMD, Inc.
 137,621 $92,618

All Filings in TEVA

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $917,131 27,070
2026-03-31 $815,348 27,070
2025-12-31 $844,854 27,070
2025-09-30 $697,910 34,550
2025-03-31 $307,400 20,000
2025-03-31 $416,527 27,100